nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxprenolol—SLC22A2—Vinblastine—testicular cancer	0.395	0.431	CbGbCtD
Oxprenolol—SLC22A2—Cisplatin—testicular cancer	0.362	0.395	CbGbCtD
Oxprenolol—CYP2D6—Vinblastine—testicular cancer	0.0991	0.108	CbGbCtD
Oxprenolol—CYP2D6—Doxorubicin—testicular cancer	0.0609	0.0664	CbGbCtD
Oxprenolol—Cardiac failure—Ifosfamide—testicular cancer	0.00167	0.0202	CcSEcCtD
Oxprenolol—Bronchospasm—Bleomycin—testicular cancer	0.00162	0.0196	CcSEcCtD
Oxprenolol—Psychotic disorder—Ifosfamide—testicular cancer	0.00159	0.0193	CcSEcCtD
Oxprenolol—Bronchospasm—Ifosfamide—testicular cancer	0.00139	0.0168	CcSEcCtD
Oxprenolol—Cardiac failure—Etoposide—testicular cancer	0.00132	0.016	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Cisplatin—testicular cancer	0.00128	0.0155	CcSEcCtD
Oxprenolol—Thrombocytopenia—Chlorambucil—testicular cancer	0.00119	0.0144	CcSEcCtD
Oxprenolol—Sweating increased—Cisplatin—testicular cancer	0.00118	0.0143	CcSEcCtD
Oxprenolol—Bradycardia—Ifosfamide—testicular cancer	0.00115	0.0139	CcSEcCtD
Oxprenolol—Bronchospasm—Etoposide—testicular cancer	0.0011	0.0133	CcSEcCtD
Oxprenolol—Thrombocytopenia—Vinblastine—testicular cancer	0.00109	0.0132	CcSEcCtD
Oxprenolol—Sweating increased—Etoposide—testicular cancer	0.00109	0.0131	CcSEcCtD
Oxprenolol—Dyspepsia—Chlorambucil—testicular cancer	0.00107	0.0129	CcSEcCtD
Oxprenolol—Fatigue—Chlorambucil—testicular cancer	0.00105	0.0126	CcSEcCtD
Oxprenolol—Bradycardia—Cisplatin—testicular cancer	0.000991	0.012	CcSEcCtD
Oxprenolol—Abnormal dreams—Epirubicin—testicular cancer	0.000984	0.0119	CcSEcCtD
Oxprenolol—Abdominal pain—Chlorambucil—testicular cancer	0.000959	0.0116	CcSEcCtD
Oxprenolol—Thrombocytopenia—Bleomycin—testicular cancer	0.000919	0.0111	CcSEcCtD
Oxprenolol—Abnormal dreams—Doxorubicin—testicular cancer	0.00091	0.011	CcSEcCtD
Oxprenolol—Hypersensitivity—Chlorambucil—testicular cancer	0.000893	0.0108	CcSEcCtD
Oxprenolol—Abdominal pain—Vinblastine—testicular cancer	0.000878	0.0106	CcSEcCtD
Oxprenolol—Hypotension—Bleomycin—testicular cancer	0.000877	0.0106	CcSEcCtD
Oxprenolol—Asthenia—Chlorambucil—testicular cancer	0.00087	0.0105	CcSEcCtD
Oxprenolol—Palpitations—Ifosfamide—testicular cancer	0.000869	0.0105	CcSEcCtD
Oxprenolol—Pruritus—Chlorambucil—testicular cancer	0.000858	0.0104	CcSEcCtD
Oxprenolol—Thrombocytopenia—Dactinomycin—testicular cancer	0.000857	0.0104	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.000855	0.0103	CcSEcCtD
Oxprenolol—Arthralgia—Ifosfamide—testicular cancer	0.000837	0.0101	CcSEcCtD
Oxprenolol—Diarrhoea—Chlorambucil—testicular cancer	0.00083	0.01	CcSEcCtD
Oxprenolol—Hypersensitivity—Vinblastine—testicular cancer	0.000819	0.0099	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000797	0.00965	CcSEcCtD
Oxprenolol—Asthenia—Vinblastine—testicular cancer	0.000797	0.00964	CcSEcCtD
Oxprenolol—Thrombocytopenia—Ifosfamide—testicular cancer	0.000785	0.0095	CcSEcCtD
Oxprenolol—Hyperhidrosis—Ifosfamide—testicular cancer	0.000775	0.00938	CcSEcCtD
Oxprenolol—Diarrhoea—Vinblastine—testicular cancer	0.00076	0.0092	CcSEcCtD
Oxprenolol—Fatigue—Dactinomycin—testicular cancer	0.000755	0.00913	CcSEcCtD
Oxprenolol—Hypotension—Ifosfamide—testicular cancer	0.000749	0.00907	CcSEcCtD
Oxprenolol—Cardiac failure—Epirubicin—testicular cancer	0.00074	0.00896	CcSEcCtD
Oxprenolol—Hypoglycaemia—Epirubicin—testicular cancer	0.00074	0.00896	CcSEcCtD
Oxprenolol—Dizziness—Vinblastine—testicular cancer	0.000735	0.00889	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000731	0.00884	CcSEcCtD
Oxprenolol—Diplopia—Epirubicin—testicular cancer	0.000723	0.00874	CcSEcCtD
Oxprenolol—Nausea—Chlorambucil—testicular cancer	0.00072	0.00871	CcSEcCtD
Oxprenolol—Headache—Vinblastine—testicular cancer	0.000696	0.00842	CcSEcCtD
Oxprenolol—Abdominal pain—Dactinomycin—testicular cancer	0.000692	0.00837	CcSEcCtD
Oxprenolol—Fatigue—Ifosfamide—testicular cancer	0.000692	0.00837	CcSEcCtD
Oxprenolol—Hypersensitivity—Bleomycin—testicular cancer	0.000691	0.00836	CcSEcCtD
Oxprenolol—Cardiac failure—Doxorubicin—testicular cancer	0.000685	0.00829	CcSEcCtD
Oxprenolol—Hypoglycaemia—Doxorubicin—testicular cancer	0.000685	0.00829	CcSEcCtD
Oxprenolol—Thrombocytopenia—Cisplatin—testicular cancer	0.000677	0.00819	CcSEcCtD
Oxprenolol—Asthenia—Bleomycin—testicular cancer	0.000673	0.00815	CcSEcCtD
Oxprenolol—Diplopia—Doxorubicin—testicular cancer	0.000669	0.00809	CcSEcCtD
Oxprenolol—Hyperhidrosis—Cisplatin—testicular cancer	0.000668	0.00809	CcSEcCtD
Oxprenolol—Pruritus—Bleomycin—testicular cancer	0.000664	0.00803	CcSEcCtD
Oxprenolol—Nausea—Vinblastine—testicular cancer	0.00066	0.00798	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Epirubicin—testicular cancer	0.00066	0.00798	CcSEcCtD
Oxprenolol—Hypotension—Cisplatin—testicular cancer	0.000646	0.00782	CcSEcCtD
Oxprenolol—Hypersensitivity—Dactinomycin—testicular cancer	0.000645	0.0078	CcSEcCtD
Oxprenolol—Abdominal pain—Ifosfamide—testicular cancer	0.000634	0.00767	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00063	0.00762	CcSEcCtD
Oxprenolol—Asthenia—Dactinomycin—testicular cancer	0.000628	0.0076	CcSEcCtD
Oxprenolol—Thrombocytopenia—Etoposide—testicular cancer	0.00062	0.0075	CcSEcCtD
Oxprenolol—Hyperhidrosis—Etoposide—testicular cancer	0.000612	0.00741	CcSEcCtD
Oxprenolol—Orthostatic hypotension—Doxorubicin—testicular cancer	0.000611	0.00739	CcSEcCtD
Oxprenolol—Diarrhoea—Dactinomycin—testicular cancer	0.000599	0.00724	CcSEcCtD
Oxprenolol—Hypotension—Etoposide—testicular cancer	0.000592	0.00716	CcSEcCtD
Oxprenolol—Hypersensitivity—Ifosfamide—testicular cancer	0.000591	0.00715	CcSEcCtD
Oxprenolol—Asthenia—Ifosfamide—testicular cancer	0.000575	0.00696	CcSEcCtD
Oxprenolol—Pruritus—Ifosfamide—testicular cancer	0.000567	0.00686	CcSEcCtD
Oxprenolol—Nausea—Bleomycin—testicular cancer	0.000557	0.00674	CcSEcCtD
Oxprenolol—Diarrhoea—Ifosfamide—testicular cancer	0.000549	0.00664	CcSEcCtD
Oxprenolol—Fatigue—Etoposide—testicular cancer	0.000546	0.00661	CcSEcCtD
Oxprenolol—Dizziness—Ifosfamide—testicular cancer	0.00053	0.00642	CcSEcCtD
Oxprenolol—Nausea—Dactinomycin—testicular cancer	0.00052	0.00629	CcSEcCtD
Oxprenolol—Hypersensitivity—Cisplatin—testicular cancer	0.000509	0.00616	CcSEcCtD
Oxprenolol—Bradycardia—Epirubicin—testicular cancer	0.000509	0.00616	CcSEcCtD
Oxprenolol—Abdominal pain—Etoposide—testicular cancer	0.000501	0.00606	CcSEcCtD
Oxprenolol—Asthenia—Cisplatin—testicular cancer	0.000496	0.006	CcSEcCtD
Oxprenolol—Nausea—Ifosfamide—testicular cancer	0.000476	0.00576	CcSEcCtD
Oxprenolol—Diarrhoea—Cisplatin—testicular cancer	0.000473	0.00572	CcSEcCtD
Oxprenolol—Bradycardia—Doxorubicin—testicular cancer	0.000471	0.0057	CcSEcCtD
Oxprenolol—Hypersensitivity—Etoposide—testicular cancer	0.000467	0.00565	CcSEcCtD
Oxprenolol—Asthenia—Etoposide—testicular cancer	0.000455	0.0055	CcSEcCtD
Oxprenolol—Pruritus—Etoposide—testicular cancer	0.000448	0.00542	CcSEcCtD
Oxprenolol—Diarrhoea—Etoposide—testicular cancer	0.000433	0.00524	CcSEcCtD
Oxprenolol—Dizziness—Etoposide—testicular cancer	0.000419	0.00507	CcSEcCtD
Oxprenolol—Nausea—Cisplatin—testicular cancer	0.000411	0.00497	CcSEcCtD
Oxprenolol—Headache—Etoposide—testicular cancer	0.000397	0.0048	CcSEcCtD
Oxprenolol—Arthralgia—Methotrexate—testicular cancer	0.000396	0.00479	CcSEcCtD
Oxprenolol—Palpitations—Epirubicin—testicular cancer	0.000385	0.00465	CcSEcCtD
Oxprenolol—Nausea—Etoposide—testicular cancer	0.000376	0.00455	CcSEcCtD
Oxprenolol—Thrombocytopenia—Methotrexate—testicular cancer	0.000372	0.00449	CcSEcCtD
Oxprenolol—Arthralgia—Epirubicin—testicular cancer	0.00037	0.00448	CcSEcCtD
Oxprenolol—Hyperhidrosis—Methotrexate—testicular cancer	0.000367	0.00444	CcSEcCtD
Oxprenolol—Palpitations—Doxorubicin—testicular cancer	0.000356	0.0043	CcSEcCtD
Oxprenolol—Hypotension—Methotrexate—testicular cancer	0.000355	0.00429	CcSEcCtD
Oxprenolol—Thrombocytopenia—Epirubicin—testicular cancer	0.000348	0.00421	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000346	0.00418	CcSEcCtD
Oxprenolol—Hyperhidrosis—Epirubicin—testicular cancer	0.000343	0.00415	CcSEcCtD
Oxprenolol—Insomnia—Methotrexate—testicular cancer	0.000343	0.00415	CcSEcCtD
Oxprenolol—Arthralgia—Doxorubicin—testicular cancer	0.000343	0.00415	CcSEcCtD
Oxprenolol—Dyspepsia—Methotrexate—testicular cancer	0.000334	0.00404	CcSEcCtD
Oxprenolol—Hypotension—Epirubicin—testicular cancer	0.000332	0.00401	CcSEcCtD
Oxprenolol—Fatigue—Methotrexate—testicular cancer	0.000327	0.00396	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000324	0.00391	CcSEcCtD
Oxprenolol—Thrombocytopenia—Doxorubicin—testicular cancer	0.000322	0.00389	CcSEcCtD
Oxprenolol—Insomnia—Epirubicin—testicular cancer	0.000321	0.00389	CcSEcCtD
Oxprenolol—Hyperhidrosis—Doxorubicin—testicular cancer	0.000318	0.00384	CcSEcCtD
Oxprenolol—Dyspepsia—Epirubicin—testicular cancer	0.000313	0.00378	CcSEcCtD
Oxprenolol—Hypotension—Doxorubicin—testicular cancer	0.000307	0.00371	CcSEcCtD
Oxprenolol—Fatigue—Epirubicin—testicular cancer	0.000306	0.0037	CcSEcCtD
Oxprenolol—Abdominal pain—Methotrexate—testicular cancer	0.0003	0.00363	CcSEcCtD
Oxprenolol—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000299	0.00362	CcSEcCtD
Oxprenolol—Insomnia—Doxorubicin—testicular cancer	0.000297	0.0036	CcSEcCtD
Oxprenolol—Dyspepsia—Doxorubicin—testicular cancer	0.000289	0.0035	CcSEcCtD
Oxprenolol—Fatigue—Doxorubicin—testicular cancer	0.000283	0.00343	CcSEcCtD
Oxprenolol—Abdominal pain—Epirubicin—testicular cancer	0.000281	0.0034	CcSEcCtD
Oxprenolol—Hypersensitivity—Methotrexate—testicular cancer	0.00028	0.00338	CcSEcCtD
Oxprenolol—Asthenia—Methotrexate—testicular cancer	0.000272	0.00329	CcSEcCtD
Oxprenolol—Pruritus—Methotrexate—testicular cancer	0.000268	0.00325	CcSEcCtD
Oxprenolol—Hypersensitivity—Epirubicin—testicular cancer	0.000262	0.00317	CcSEcCtD
Oxprenolol—Abdominal pain—Doxorubicin—testicular cancer	0.00026	0.00314	CcSEcCtD
Oxprenolol—Diarrhoea—Methotrexate—testicular cancer	0.00026	0.00314	CcSEcCtD
Oxprenolol—Asthenia—Epirubicin—testicular cancer	0.000255	0.00308	CcSEcCtD
Oxprenolol—Pruritus—Epirubicin—testicular cancer	0.000251	0.00304	CcSEcCtD
Oxprenolol—Dizziness—Methotrexate—testicular cancer	0.000251	0.00304	CcSEcCtD
Oxprenolol—Diarrhoea—Epirubicin—testicular cancer	0.000243	0.00294	CcSEcCtD
Oxprenolol—Hypersensitivity—Doxorubicin—testicular cancer	0.000242	0.00293	CcSEcCtD
Oxprenolol—Headache—Methotrexate—testicular cancer	0.000238	0.00288	CcSEcCtD
Oxprenolol—Asthenia—Doxorubicin—testicular cancer	0.000236	0.00285	CcSEcCtD
Oxprenolol—Dizziness—Epirubicin—testicular cancer	0.000235	0.00284	CcSEcCtD
Oxprenolol—Pruritus—Doxorubicin—testicular cancer	0.000232	0.00281	CcSEcCtD
Oxprenolol—Nausea—Methotrexate—testicular cancer	0.000225	0.00273	CcSEcCtD
Oxprenolol—Diarrhoea—Doxorubicin—testicular cancer	0.000225	0.00272	CcSEcCtD
Oxprenolol—Headache—Epirubicin—testicular cancer	0.000222	0.00269	CcSEcCtD
Oxprenolol—Dizziness—Doxorubicin—testicular cancer	0.000217	0.00263	CcSEcCtD
Oxprenolol—Nausea—Epirubicin—testicular cancer	0.000211	0.00255	CcSEcCtD
Oxprenolol—Headache—Doxorubicin—testicular cancer	0.000206	0.00249	CcSEcCtD
Oxprenolol—Nausea—Doxorubicin—testicular cancer	0.000195	0.00236	CcSEcCtD
